Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Interleukin 13 and its role in gut defence and inflammation.

Mannon P, Reinisch W.

Gut. 2012 Dec;61(12):1765-73. doi: 10.1136/gutjnl-2012-303461. Review.

PMID:
22942239
3.

Absence of a role for interleukin-13 in inflammatory bowel disease.

Biancheri P, Di Sabatino A, Ammoscato F, Facciotti F, Caprioli F, Curciarello R, Hoque SS, Ghanbari A, Joe-Njoku I, Giuffrida P, Rovedatti L, Geginat J, Corazza GR, MacDonald TT.

Eur J Immunol. 2014 Feb;44(2):370-85. doi: 10.1002/eji.201343524.

4.

Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Camelo A, Barlow JL, Drynan LF, Neill DR, Ballantyne SJ, Wong SH, Pannell R, Gao W, Wrigley K, Sprenkle J, McKenzie AN.

J Gastroenterol. 2012 Nov;47(11):1198-211. doi: 10.1007/s00535-012-0591-2.

5.

Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFN╬│.

Mann ER, Bernardo D, Ng SC, Rigby RJ, Al-Hassi HO, Landy J, Peake ST, Spranger H, English NR, Thomas LV, Stagg AJ, Knight SC, Hart AL.

Inflamm Bowel Dis. 2014 Dec;20(12):2299-307. doi: 10.1097/MIB.0000000000000223.

PMID:
25397892
6.

An overview of the role of innate lymphoid cells in gut infections and inflammation.

Sedda S, Marafini I, Figliuzzi MM, Pallone F, Monteleone G.

Mediators Inflamm. 2014;2014:235460. doi: 10.1155/2014/235460. Review.

7.

The role of IL-33 in gut mucosal inflammation.

Pastorelli L, De Salvo C, Vecchi M, Pizarro TT.

Mediators Inflamm. 2013;2013:608187. doi: 10.1155/2013/608187. Review.

8.

Primary eosinophilic disorders of the gastrointestinal tract.

Yan BM, Shaffer EA.

Gut. 2009 May;58(5):721-32. doi: 10.1136/gut.2008.165894. Review.

PMID:
19052023
9.

Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection.

McDermott JR, Humphreys NE, Forman SP, Donaldson DD, Grencis RK.

J Immunol. 2005 Sep 1;175(5):3207-13.

10.

Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease.

Leung J, Hang L, Blum A, Setiawan T, Stoyanoff K, Weinstock J.

Inflamm Bowel Dis. 2012 Aug;18(8):1447-55. doi: 10.1002/ibd.22858.

11.

Immune modulation for treatment of allergic disease.

Nguyen TH, Casale TB.

Immunol Rev. 2011 Jul;242(1):258-71. doi: 10.1111/j.1600-065X.2011.01034.x. Review.

PMID:
21682751
12.

Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.

Shen W, Durum SK.

Neurochem Res. 2010 Jun;35(6):940-6. doi: 10.1007/s11064-009-0091-9. Review.

PMID:
19915978
13.

Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.

Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, MacDonald TT, Monteleone G.

Gastroenterology. 2009 Jun;136(7):2270-9. doi: 10.1053/j.gastro.2009.02.049.

PMID:
19505427
14.

Regulatory lymphocytes and intestinal inflammation.

Izcue A, Coombes JL, Powrie F.

Annu Rev Immunol. 2009;27:313-38. doi: 10.1146/annurev.immunol.021908.132657. Review.

PMID:
19302043
15.

The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.

Stecher B.

Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.

PMID:
26185088
16.

New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation.

Bamias G, Corridoni D, Pizarro TT, Cominelli F.

Cytokine. 2012 Sep;59(3):451-9. doi: 10.1016/j.cyto.2012.06.014. Review.

17.

Interleukin-23 and Th17 cells in the control of gut inflammation.

Monteleone I, Pallone F, Monteleone G.

Mediators Inflamm. 2009;2009:297645. doi: 10.1155/2009/297645. Review.

18.

Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.

Judd LM, Heine RG, Menheniott TR, Buzzelli J, O'Brien-Simpson N, Pavlic D, O'Connor L, Al Gazali K, Hamilton O, Scurr M, Collison AM, Mattes J, Allen KJ, Giraud AS.

Am J Physiol Gastrointest Liver Physiol. 2016 Jan 1;310(1):G13-25. doi: 10.1152/ajpgi.00290.2015.

19.

Therapeutic activity of an interleukin-4/interleukin-13 dual antagonist on oxazolone-induced colitis in mice.

Kasaian MT, Page KM, Fish S, Brennan A, Cook TA, Moreira K, Zhang M, Jesson M, Marquette K, Agostinelli R, Lee J, Williams CM, Tchistiakova L, Thakker P.

Immunology. 2014 Nov;143(3):416-27. doi: 10.1111/imm.12319.

20.

The IL-23/IL-17 pathway in inflammatory bowel disease.

Geremia A, Jewell DP.

Expert Rev Gastroenterol Hepatol. 2012 Apr;6(2):223-37. doi: 10.1586/egh.11.107. Review.

PMID:
22375527
Items per page

Supplemental Content

Support Center